1. | | Recruiting | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Condition: Prostate Cancer |
2. | | Recruiting | A 14-day study of Racivir when used in combination in HIV-Infected Males Condition: HIV Infections |
3. | | Recruiting | 2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting Condition: Postoperative Nausea and Vomiting |
4. | | Recruiting | 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting Condition: Postoperative Nausea and Vomiting |
5. | | Recruiting | A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). Condition: Prostatic Hyperplasia |
6. | | Recruiting | A 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma Condition: Asthma |
7. | | Recruiting | 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia Condition: Schizophrenia |
8. | | Recruiting | 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
9. | | Recruiting | 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection Condition: HIV Infections |
10. | | Recruiting | A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
11. | | Recruiting | A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT) Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
12. | | Recruiting | Abciximab (ReoPro) in Acute Ischemic Stroke Condition: Stroke |
13. | | Recruiting | ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer Conditions: Colorectal Cancer; Metastases |
14. | | Recruiting | Active Crohn’s Disease Study Condition: Crohn Disease |
15. | | Recruiting | Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes Condition: Diabetes Mellitus, Non-Insulin-Dependent |
16. | | Recruiting | Acute Myeloid Leukemia Study Condition: Acute Myeloid Leukemia |
17. | | Recruiting | Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease Condition: Crohn's Disease |
18. | | Recruiting | Adjunct CellCept (mycophenolate mofetil) with Reduced Corticosteroids in Subjects with Myasthenia Gravis Condition: Myasthenia Gravis |
19. | | Not yet recruiting | Adult Primary Insomnia Polysomnographic Study Condition: Primary Insomnia |
20. | | Recruiting | Advanced Or Metastatic Non-Small Cell Lung Cancer Study In Patients Who Have Received One Platinum-based Chemotherapy Condition: Non-small cell lung cancer |
21. | | Recruiting | Advanced Renal Cell Carcinoma Conditions: Carcinoma, Renal Cell; Kidney Neoplasms |
22. | | Recruiting | AG-858 in Patients who are Cytogenetically Positive after Treatment with Gleevec™ Condition: Leukemia, Myeloid, Chronic |
23. | | Recruiting | Alfimeprase for thrombolysis in Acute Peripheral Arterial Occlusion Conditions: Arterial Occlusive Diseases; Peripheral Vascular Diseases; Thrombosis |
24. | | Recruiting | Alimta (pemetrexed) and Cisplatin versus Gemzar (gemcitabine) and Cisplatin in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Condition: Non Small Cell Lung Carcinoma |
25. | | Recruiting | ALIMTA (pemetrexed) and Gemcitabine (gemzar) in Patients with Advanced Cancer Condition: Neoplasms |
26. | | Recruiting | Alimta (pemetrexed) in Patients with Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy Condition: Non-Small-Cell Lung Carcinoma |
27. | | Recruiting | Alimta (pemetrexed) plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma Condition: Pleural Neoplasms |
28. | | Recruiting | ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have not had previous chemotherapy. Condition: Carcinoma, Non-Small-Cell Lung |
29. | | Recruiting | ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy Condition: Mesothelioma |
30. | | Recruiting | Alimta (pemetrexed) plus Gemzar (gemcitabine) in metastatic breast cancer patients after receiving Taxane therapy. Condition: Breast Cancer |
31. | | Recruiting | AMG 162 in Biphosphonate Naive Metastatic Breast Cancer Conditions: Breast Cancer; Metastases |
32. | | Recruiting | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer Condition: Prostate Cancer |
33. | | Recruiting | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer Condition: Breast Cancer |
34. | | Recruiting | Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer Condition: Breast Cancer |
35. | | Recruiting | Anastrozole With or Without Trastuzumab in Treating Postmenopausal Women With Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
36. | | Recruiting | Angiomax in Patients with HIT/HITTS Type II Undergoing CPB Conditions: Cardiovascular Disease; Coronary Artery Bypass Surgery |
37. | | Recruiting | Angiomax in Patients with HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) Conditions: Thrombocytopenia; Thrombosis; Cardiac Disease; Coronary Artery Bypass Surgery |
38. | | Not yet recruiting | Anti-angiogenesis Agent AG-013736 in Patients with Advanced Non-Small Cell Lung Cancer Conditions: Non-Small-Cell Lung Carcinoma; Metastases |
39. | | Not yet recruiting | Anti-angiogenesis Agent AG-013736 in Patients with Metastatic Melanoma Conditions: Melanoma; Metastases |
40. | | Recruiting | Antibiotic Treatment for Patients with Infections of Short Term In-dwelling Vascular Catheters Due to a Specific Bacteria (Gram Positive Bacteria) Conditions: Bacterial Infections; Gram-Positive Bacterial Infections; Bacteremia |
41. | | Recruiting | Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study Condition: Alzheimer Disease |
42. | | Recruiting | ARIES - Ambrisentan in Patients with Moderate to Severe Pulmonary Arterial Hypertension (PAH) Condition: Pulmonary Hypertension |
43. | | Recruiting | Arimidex in McCune Albright Syndrome Condition: McCune-Albright Syndrome |
44. | | Recruiting | ARISE – Aggressive Reduction of Inflammation Stops Events Conditions: Atherosclerosis; Coronary Artery Disease; Myocardial Infarction; Unstable Angina |
45. | | Recruiting | ARQ 501 in Subjects with Cancer Condition: Cancer |
46. | | Not yet recruiting | Autologous Cultured Myoblasts (BioWhittaker) Transplanted via Myocardial Injection Conditions: Congestive Heart Failure; Coronary Artery Disease; Myocardial Infarction |
47. | | Recruiting | Autologous Incubated Macrophages for Patients with Complete Spinal Cord Injuries Condition: Spinal Cord Injury |
48. | | Recruiting | Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients Condition: Chronic Lymphocytic Leukemia |
49. | | Recruiting | Avastin With or Without Erlotinib for Treatment of Metastatic Renal Cell Carcinoma Condition: Renal Cell Cancer |
50. | | Recruiting | AZD5438 in Patients with Advanced Solid Malignancies Condition: advanced, solid, malignancies |